1. Flow Diagram of the Trial Selection Process Jeffrey S. Berger et al, JAMA. 2006;295:306-313

2. Design of Trials Included in the Meta-analysis Jeffrey S. Berger et al, JAMA. 2006;295:306-313

3. Characteristics of Men and Women Included in Trials of Aspirin for the Primary Prevention of Cardiovascular Disease* Jeffrey S. Berger et al, JAMA. 2006;295:306-313

4. Effect of Aspirin Treatment on the Primary Prevention of Major Cardiovascular Events and Myocardial Infarction Jeffrey S. Berger et al, JAMA. 2006;295:306-313

5. Effect of Aspirin Treatment on the Primary Prevention of Stroke, Ischemic Stroke, and Hemorrhagic Stroke Jeffrey S. Berger et al, JAMA. 2006;295:306-313

6. Effect of Aspirin Treatment on the Primary Prevention of Cardiovascular Mortality and Total Mortality Jeffrey S. Berger et al, JAMA. 2006;295:306-313

7. Effect of Aspirin Treatment on Major Bleeding Jeffrey S. Berger et al, JAMA. 2006;295:306-313